News
17h
News-Medical.Net on MSNTirzepatide tops the charts for blood sugar and weight loss in type 2 diabetesA large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
9h
GlobalData on MSNMorphic Medical obtains CE mark for obesity treatmentMorphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 ...
Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...
3hon MSN
A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...
Fibromyalgia patients taking GLP-1s have lower rates of opioid use, pain, fatigue, and malaise in a real-world patient data ...
Several top nutrition and obesity organizations provided the first unified guidelines for helping patients manage their ...
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results